Julian Baker’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Hold
310,483
0.01% 81
2026
Q1
$894K Hold
310,483
0.01% 81
2025
Q4
$1.26M Sell
310,483
-1,720,466
-85% -$7.7M 0.01% 80
2025
Q3
$7.21M Hold
2,030,949
0.05% 67
2025
Q2
$5.54M Hold
2,030,949
0.05% 66
2025
Q1
$3.41M Sell
2,030,949
-350,000
-15% -$978K 0.04% 67
2024
Q4
$3.88M Hold
2,380,949
0.04% 76
2024
Q3
$9.9M Hold
2,380,949
0.1% 53
2024
Q2
$13M Hold
2,380,949
0.17% 44
2024
Q1
$23.8M Buy
2,380,949
+380,949
+19% +$2.85M 0.3% 37
2023
Q4
$8.16M Hold
2,000,000
0.09% 52
2023
Q3
$7.74M Hold
2,000,000
0.04% 53
2023
Q2
$11.9M Hold
2,000,000
0.07% 52
2023
Q1
$6.54M Buy
+2,000,000
New +$7.99M 0.04% 63

Other funds holding SANA

Julian Baker's SANA Position: Q2 2026 in Review

Julian Baker held its Sana Biotechnology (SANA) position steady in Q2 2026 at 310,483 shares worth $1.08M. The position accounts for 0.01% of the portfolio, ranked #81.

Julian Baker first reported a position in SANA in Q1 2023 and has held it in 14 quarters since. The position peaked at $23.8M in Q1 2024. 208 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Julian Baker held 310,483 shares of Sana Biotechnology worth $1.08M as of Q2 2026.
  • Julian Baker left its Sana Biotechnology share count unchanged in Q2 2026.
  • Sana Biotechnology made up 0.01% of Julian Baker's portfolio in Q2 2026, its #81 holding.
  • Julian Baker first reported a position in Sana Biotechnology in Q1 2023 and has held it in 14 quarters since.
  • Julian Baker's Sana Biotechnology position peaked at $23.8M in Q1 2024.
  • 208 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Baker Bros. Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.